Australia markets open in 12 minutes

VentriPoint Diagnostics Ltd. (VPTDF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1676+0.0044 (+2.70%)
At close: 03:32PM EDT

VentriPoint Diagnostics Ltd.

18 Hook Avenue
Unit 101
Toronto, ON M6P 1T4
Canada
416-848-4156
https://www.ventripoint.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D.Executive Chairman & Corporate Secretary208.74kN/A1948
Mr. Hugh MacNaughtInterim CEO, President & Director8.76kN/AN/A
Mr. Jimmy JeonChief Financial OfficerN/AN/AN/A
Mr. Hirotaka KatagiriCTO & Business Development Division DirectorN/AN/AN/A
Mr. Jim GrabaApplication Specialist & Chief TrainerN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.

Corporate governance

VentriPoint Diagnostics Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.